Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity Analysis.
about
Comparative Evaluation of the Chemical Stability of 4 Well-Defined Immunoglobulin G1-Fc GlycoformsThe Botanical Drug Substance Crofelemer as a Model System for Comparative Characterization of Complex Mixture Drugs.A Multidimensional Analytical Comparison of Remicade and the Biosimilar Remsima.Effects of N-Glycan Composition on Structure and Dynamics of IgG1 Fc and Their Implications for Antibody Engineering.A library of chemically defined human N-glycans synthesized from microbial oligosaccharide precursors.Synthesis of a Bifunctional Peptide Inhibitor-IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis.Structural characterization of the Man5 glycoform of human IgG3 Fc.Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry
P2860
Q28820826-C80E9D6F-1994-4CA7-99CB-1C1772577171Q38661672-40BD3E74-1FA0-43E4-BDBE-397CADB7CFCAQ38736575-3C5404EB-4E44-45DA-9FB8-EC4CEBD15D5AQ42171615-B2FBC098-2952-47E8-9454-F522DB91757CQ44751842-FD4F4C66-409D-4DF6-BC8C-E5DCDB128061Q46299475-BB6C7330-EC4C-420C-951E-0B34EEAAD7C8Q47445247-70D6709A-A6E8-44DC-9A3A-88FB3E328F6FQ50508037-55015E47-2A40-4C57-A954-DC082EDCB388Q57165000-4B081790-1FBE-4EF9-9AB7-7107B174B030
P2860
Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity Analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Production, Characterization, ...... em for Biosimilarity Analysis.
@en
type
label
Production, Characterization, ...... em for Biosimilarity Analysis.
@en
prefLabel
Production, Characterization, ...... em for Biosimilarity Analysis.
@en
P2093
P2860
P1476
Production, Characterization, ...... em for Biosimilarity Analysis.
@en
P2093
Apurva S More
C Russell Middaugh
David B Volkin
Derek R White
Ishan S Shah
Sangeeta B Joshi
Shaofeng Duan
Solomon Z Okbazghi
Thomas J Tolbert
P2860
P304
P356
10.1016/J.XPHS.2015.11.003
P407
P577
2016-01-09T00:00:00Z